About My Health Careers Internship MedBlogs Contact us

Advanced Skin Cancer Responds Well To Combination With Immunotherapy

Font : A-A+

  • Melanoma is the deadliest form of skin cancer, most of which have a BRAF mutation.
  • The study looked at the most effective treatment for patients diagnosed with advanced BRAF-mutated melanoma but not yet received any treatment.
  • Targeted therapy with chemotherapy drugs was effective in improving progression-free survival.
  • Immunotherapy was associated with lowest risk of life-threatening events.

Advanced Skin Cancer Responds Well To Combination With Immunotherapy

Patients that are diagnosed in the late stages of one of the most common and deadly forms of skin cancer, melanoma, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events.

Cutaneous melanoma is an aggressive and deadly form of skin cancer.


According to the Canadian Cancer Society, the disease accounts for 3.3% of new cancer cases each year in Canada, and it has a 15% death rate.

In its early stages, melanoma is often cured with surgery alone, however most patients who are diagnosed in the late stages of disease are not candidates for surgery and drug therapy is the main course of treatment.

The study was conducted by researchers from the McMaster University and published in JAMA Oncology.

"This is the first analysis to draw comparison between targeted and immune therapies for BRAF-mutated melanomas," said Feng Xie, principal investigator of the study, who is an associate professor in the Department of Clinical Epidemiology and Biostatistics at McMaster's Michael G. DeGroote School of Medicine.

"Our results will help patients and clinicians choose treatments." Xie added.

Tahira Devji, the first author of the paper and a PhD student of McMaster's Health Research Methodology Program, said that around 40 to 60 per cent of melanomas have a mutation in the BRAF protein.

A number of effective treatment options are available for patients with advanced BRAF-mutated melanoma, which fall under two classes of drug therapies:
  • targeted therapy, like chemotherapy, which stops cancer from growing and spreading
  • immunotherapy, which works by stimulating the immune system to attack tumor cells.
It has been unclear which is the optimal initial treatment.

The goal of the study was to estimate the relative efficacy and safety of systemic therapies for those who have been diagnosed with advanced BRAF-mutated melanoma but not yet received any treatment.

The team evaluated 15 randomized controlled trials published between 2011 and 2015, assessing the benefits and harms of targeted or immune checkpoint inhibitors in 6,662 patients with cancer that had spread to the lymph nodes and surgery was not an option, or distant metastatic melanoma.

They found that combined BRAF and MEK targeted therapy and PD-1 immunotherapy were both equally effective in improving overall survival.

Combined BRAF and MEK inhibition was most effective in improving progression-free survival.

PD-1 inhibition was associated with the lowest risk of life-threatening events.

PD-1 is a checkpoint protein on immune cells called T cells.

It normally acts as a type of "off switch" that helps keep the T cells from attacking other cells in the body. It does this when it attaches to PD-L1, a protein on some normal (and cancer) cells.

When PD-1 binds to PD-L1, it basically tells the T cell to leave the other cell alone. Some cancer cells have large amounts of PD-L1, which helps them evade immune attack.

Monoclonal antibodies that target either PD-1 or PD-L1 can boost the immune response against cancer cells and have shown a great deal of promise in treating certain cancers.

"While the data in our study represents best available evidence, using more than one kind of immunotherapy shows promise in early outcomes in clinical trials and could change the treatment landscape once longer-term results are published," said Feng Xie.

They concluded that the safety of PD-1 inhibitors supports using this treatment option as first-line therapy in circumstances where quick action is not a priority.

  1. Immune checkpoint inhibitors to treat cancer - (http://www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/immunotherapy/cancer-immunotherapy-immune-checkpoint-inhibitors)

Source: Medindia

News A-Z
News Category
What's New on Medindia
Fermented Skin Care
Television Binge-Watching May Boost the Risk of Deadly Blood Clots
Western Diet may Augment the Risk of Autoimmune Diseases
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Boils / Skin Abscess Skin Cancer Cancer and Homeopathy Immunisation Ultra-Violet Radiation Cancer Facts Pityriasis rosea Cancer Tattoos A Body Art Pemphigus 

Recommended Reading
Melanoma is a dangerous form of skin cancer caused largely due to exposure to the sun's damaging UV ...
New Treatment Resistant Mechanism Identified In BRAF Mutant Melanoma
Inactivation of tumor suppressors STAG2 or STAG3 reactivates cell-growth signaling pathway in BRAF ....
Ipilimumab Combined With Local Treatments Improve Survival for Melanoma Patients
Local peripheral treatments are not used to cure patients with malignant melanoma; rather, they are ...
N-Acetyl Cysteine Improves Effectiveness for Melanoma
Culturing T cells in N-acetyl cysteine (NAC) before they are infused as immunotherapy improves ......
Boils / Skin Abscess
Encyclopedia section of medindia gives general info about Boils / Skin Abscess ...
Pemphigus is a rare group of autoimmune diseases that affect the skin and mucous membranes causing b...
Pityriasis Rosea
Pityriasis rosea is a common skin disease that is not contagious. It manifests as oval-shaped, pink ...
Skin Cancer
Skin cancer is an abnormal growth of skin cells. It can develop due to a continuous exposure to sun ...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Ultra-Violet Radiation
Ultraviolet radiations are electromagnetic radiations with wavelengths shorter than the shortest wav...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)